Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24135919.
- Also identified by DOI 10.1038/ncomms3617 and PMC identifier 4107456.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Global 'multi-omics' profiling of cancer cells harbours the potential for characterizing the signalling networks associated with specific oncogenes. Here we profile the transcriptome, proteome and phosphoproteome in a panel of non-small cell lung cancer (NSCLC) cell lines in order to reconstruct targetable networks associated with KRAS dependency. We develop a two-step bioinformatics strategy addressing the challenge of integrating these disparate data sets. We first define an 'abundance-score' combining transcript, protein and phospho-protein abundances to nominate differentially abundant proteins and then use the Prize Collecting Steiner Tree algorithm to identify functional sub-networks. We identify three modules centred on KRAS and MET, LCK and PAK1 and β-Catenin. We validate activation of these proteins in KRAS-dependent (KRAS-Dep) cells and perform functional studies defining LCK as a critical gene for cell proliferation in KRAS-Dep but not KRAS-independent NSCLCs. These results suggest that LCK is a potential druggable target protein in KRAS-Dep lung cancers.
Medical subject headings
- Antineoplastic Agents
- Computational Biology
- Gene Expression Regulation, Neoplastic
- Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
- Phosphoproteins
- Proto-Oncogene Proteins
- ras Proteins